Real World Experience of Ustekinumab Therapy in Patients at a US Tertiary Inflammatory Bowel Disease Center

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Normatov, Inessa [1 ]
Buisson, Anthony [2 ]
Glick, Laura R. [3 ]
Zmeter, Nada [1 ]
Pekow, Joel [4 ]
Cohen, Russell [1 ]
Rubin, David T. [5 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Chicago Med, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00679
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
679
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [31] Small Bowel Cancer Complicating Inflammatory Bowel Disease: A Tertiary Referral Center Experience
    Chablani, Sumedha
    Shen, Carlita
    Binion, David
    de Rivers, Claudia Ramos del Aguila
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S378 - S378
  • [32] Real-World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care Hospital
    Kartikeya, Tripathi
    Kevin, Groudan
    Jean, Chalhoub
    Arushika, Yedla
    Rohit, Singhania
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S17 - S17
  • [33] Real World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care University Hospital
    Tripathi, Kartikeya
    Groudan, Kevin
    Chalhoub, Jean
    Tabbalat, Rinad
    Singhania, Rohit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1368 - S1368
  • [34] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [35] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2019, 156 (03) : S36 - S37
  • [36] THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: REAL WORLD EXPERIENCE
    Shalabi, Ahmed
    Banerjee, Rwiti
    Padley, Jessica
    Appleby, Richard
    Johnston, Emma
    GUT, 2021, 70 : A120 - A120
  • [37] Therapeutic Drug Monitoring of Biologics in Patients With Inflammatory Bowel Disease: A Real World Experience
    Fourment, Chris
    Ritter, Timothy E.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S416 - S417
  • [38] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S26 - S26
  • [39] RISANKIZUMAB EFFECTIVENESS IN USTEKINUMAB-NAIVE AND USTEKINUMAB EXPERIENCED PATIENTS WITH CHROHN'S DISEASE: REAL WORLD DATA FROM A LARGE TERTIARY CENTER
    Zinger, Adar
    Choi, David
    Choi, Natalie K.
    Fear, Evan N.
    Fine, Zachary D.
    Cohen, Russell D.
    Dalal, Sushila R.
    Cleveland, Noa Krugliak
    Pekow, Joel
    Rubin, David T.
    GASTROENTEROLOGY, 2024, 166 (05) : S281 - S281
  • [40] Biosimilar Infliximab Is Effective and Safe in Inflammatory Bowel Disease Patients Naive to Anti-TNF Therapy: A Tertiary Center Experience
    Bortlik, Martin
    Kolar, Martin
    Duricova, Dana
    Malickova, Karin
    Hruba, Veronika
    Machkova, Nadezda
    Mitrova, Katarina
    Lukas, Martin
    Lukas, Milan
    GASTROENTEROLOGY, 2016, 150 (04) : S106 - S106
12345